Eric Lefkofsky: The New Sheriff in Town

Thanks to people such as Eric Lefkofsky, the fight against cancer has become more effective. In recent years, cancer has become an ongoing battle in America. In fact, it remains as relevant as America’s fight against terrorism. With that being said, cancer does not discriminate. Each year, people from all walks of life succumb to the perils of having cancer. Fortunately, there remains a glimmer of hope. Around the clock, scientists and researchers work tirelessly to devise a cure that will save the lives of millions. Moreover, few people remain as dedicated as Eric Lefkofsky.

For those unaware, Eric Lefkosky remains a man of praise and honor. Not only did he create the insanely successful business Groupon, he also developed a company aimed at fighting cancer. Moreover, the name of the company remains Tempus. Due to Eric’s goal of bringing change to cancer patients, Tempus remains extremely inclusive regarding the latest trends in technology. Furthermore, the company created its own operating system to fight cancer. In addition, Eric Lefkofsky remains the founder of Lightbank. Lightbank remains an investment company rooted in disruptive technologies and learn more about Eric.

Although many people may wonder why Eric Lefkofsky delved into finding cures for cancer, the answer remains simple. Eric remains dedicated to finding a cure for his wife’s breast cancer. Therefore, she remains fighting for her life. In addition, Lefkofsky created a foundation in honor of her. The name of the foundation remains the Lefkofsky Family Foundation. Also, Lefkofsky serves numerous positions at other cancer-fighting agencies. Moreover, Lefkofsky hails from an educated background.

Therefore, he possesses the credentials necessary to research and create cures for cancer. Moreover, Lefkofsky remains an esteemed graduate of the University of Michigan. In addition, he earned his Juris Doctor at the University of Michigan Law School. Recently, Tempus provided details regarding their partnership with the University of Chicago Medicine. Moreover, the partnership remains focused on analyzing cancer patients and creating a treatment plan for them. Moreover, the company stated that they will analyze data retrieved from about 1,000 breast cancer patients. Therefore, they will know how cancer patients respond to their treatment.

More visit: www.forbes.com/profile/eric-lefkofsky